Variants in the SLC25A1 gene are associated with a severe neurometabolic disease, D-2- and L-2-hydroxyglutaric aciduria (D/L-2-HGA), which is characterized clinically by severe developmental delay, hypotonia, and seizures [2–4]. Here, SLC25A1 is linked to Global developmental delay.